NPS's Nader on Drug Research, Growth Strategy

Feb. 25 (Bloomberg) -- Francois Nader, chief excutive officer for NPS Pharmaceuticals Inc., talks about cost strategy and product development. Nader speaks with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance." Stanley Collender, managing director for Qorvis Communications LLC, also speaks. (Source: Bloomberg)
Charter Stock Hits All-Time High
09:13 - Bloomberg’s Scarlet Fu reports on today’s top markets stories. She speaks on “Street Smart.”
  • What to Expect from Friday's Monthly Jobs Report?
  • How Could the Bond Market React to a Greek Exit?
  • Will Home Prices Rise If Interest Rates Increase?